Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
Clinical trial NCT06225843 · RECRUITING
Trial details
- NCT number
- NCT06225843
- Sponsor
- Alethia Biotherapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2026-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.